Cargando…

Changing Prescription Drug Sector: New Expenditure Methodologies

Estimating spending for prescription drugs has become increasingly difficult over the past 15 years as extensive changes have taken place within the retail prescription drug industry. Expenditures for prescription drugs in retail outlets grew rapidly during the 1980s and early 1990s. New retail outl...

Descripción completa

Detalles Bibliográficos
Autores principales: Genuardi, James S., Stiller, Jean M., Trapnell, Gordon R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193600/
https://www.ncbi.nlm.nih.gov/pubmed/10158730
_version_ 1782339004610379776
author Genuardi, James S.
Stiller, Jean M.
Trapnell, Gordon R.
author_facet Genuardi, James S.
Stiller, Jean M.
Trapnell, Gordon R.
author_sort Genuardi, James S.
collection PubMed
description Estimating spending for prescription drugs has become increasingly difficult over the past 15 years as extensive changes have taken place within the retail prescription drug industry. Expenditures for prescription drugs in retail outlets grew rapidly during the 1980s and early 1990s. New retail outlets emerged and existing sites lost market share. New mechanisms for reimbursing drug purchases led to the flow of rebates between manufacturers and insurers, bypassing retailers. These and other major industry changes required the development of new estimating methodologies for tracking prescription drug expenditures within the National Health Accounts (NHA).
format Online
Article
Text
id pubmed-4193600
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41936002014-11-04 Changing Prescription Drug Sector: New Expenditure Methodologies Genuardi, James S. Stiller, Jean M. Trapnell, Gordon R. Health Care Financ Rev Managed Care: Advances in Financing Estimating spending for prescription drugs has become increasingly difficult over the past 15 years as extensive changes have taken place within the retail prescription drug industry. Expenditures for prescription drugs in retail outlets grew rapidly during the 1980s and early 1990s. New retail outlets emerged and existing sites lost market share. New mechanisms for reimbursing drug purchases led to the flow of rebates between manufacturers and insurers, bypassing retailers. These and other major industry changes required the development of new estimating methodologies for tracking prescription drug expenditures within the National Health Accounts (NHA). CENTERS for MEDICARE & MEDICAID SERVICES 1996 /pmc/articles/PMC4193600/ /pubmed/10158730 Text en
spellingShingle Managed Care: Advances in Financing
Genuardi, James S.
Stiller, Jean M.
Trapnell, Gordon R.
Changing Prescription Drug Sector: New Expenditure Methodologies
title Changing Prescription Drug Sector: New Expenditure Methodologies
title_full Changing Prescription Drug Sector: New Expenditure Methodologies
title_fullStr Changing Prescription Drug Sector: New Expenditure Methodologies
title_full_unstemmed Changing Prescription Drug Sector: New Expenditure Methodologies
title_short Changing Prescription Drug Sector: New Expenditure Methodologies
title_sort changing prescription drug sector: new expenditure methodologies
topic Managed Care: Advances in Financing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193600/
https://www.ncbi.nlm.nih.gov/pubmed/10158730
work_keys_str_mv AT genuardijamess changingprescriptiondrugsectornewexpendituremethodologies
AT stillerjeanm changingprescriptiondrugsectornewexpendituremethodologies
AT trapnellgordonr changingprescriptiondrugsectornewexpendituremethodologies